Bernann McKinney from the U.S. holds one of five cloned puppies, the offspring of her late bullterrier Booger, upon her first meeting with them at the Seoul National University Hospital for Animals in Seoul August 5, 2008. RNL Bio, a South Korean company dedicated to the development of stem cell therapeutics and the commercialization of dog cloning technology, announced on Tuesday that the firm successfully cloned McKinney's pet dog and was commencing its world-wide dog cloning services. Five clones, named Booger Bernann, Booger Ra, Booger Lee, Booger Hong and Booger Park, were born from two surrogate mother dogs on July 28, 2008. Reuters Pictures 11 months ago

Bernann McKinney from the U.S. holds one of five cloned puppies, the offspring of her late bullterrier Booger, upon her first meeting with them at the Seoul National University Hospital for Animals in Seoul August 5, 2008. RNL Bio, a South Korean company dedicated to the development of stem cell therapeutics and the commercialization of dog cloning technology, announced on Tuesday that the firm successfully cloned McKinney's pet dog and was commencing its world-wide dog cloning services. Five clones, named Booger Bernann, Booger Ra, Booger Lee, Booger Hong and Booger Park, were born from two surrogate mother dogs on July 28, 2008.